|
Market Closed -
Euronext Dublin
11:55:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 6.250 EUR | -9.42% |
|
-10.07% | -18.83% |
| 10-23 | Malin Corp writes off investee after US FDA drug rejection | AN |
| 08-26 | Malin swings to interim profit as finance income rises and costs fall | AN |
| Market Cap | 27.09M 30.34M 25.03M 22.68M 42.44M 2.88B 43.14M 301M 119M 1.51B 114M 111M 4.76B | P/E 2024 * |
-
| P/E 2025 | -8.37x |
|---|---|---|---|---|---|
| Enterprise Value | 14.19M 15.9M 13.11M 11.88M 22.23M 1.51B 22.6M 158M 62.47M 791M 59.65M 58.38M 2.49B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
63.83% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -9.42% | ||
| 1 week | -10.07% | ||
| Current month | -10.71% | ||
| 1 month | -10.71% | ||
| 3 months | -11.97% | ||
| 6 months | -21.38% | ||
| Current year | -18.83% |
| 1 week | 6.25 |  | 6.95 |
| 1 month | 6.25 | | 7 |
| Current year | 6.25 | | 8.45 |
| 1 year | 6.25 | | 9.3 |
| 3 years | 3.84 | | 10.4 |
| 5 years | 3.59 | | 10.4 |
| 10 years | 1.4 | | 13.24 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrea Stafford
DFI | Director of Finance/CFO | 56 | 2022-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
William Daniel
CHM | Chairman | 73 | 2019-08-01 |
| Director/Board Member | 67 | 2018-07-15 | |
Rudy Mareel
BRD | Director/Board Member | 63 | 2018-07-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/2/26 | Exercice | 10,307 | 0.2382% | |||
| 5/28/25 | Exercice | Chief Executive Officer | 5,746 | 0.1328% | ||
| 4/7/25 | Sell | Director | 11,075 | 0.2560% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -9.42% | -10.07% | -24.70% | +47.41% | 30.34M | |
| -2.54% | +1.31% | +54.27% | +114.96% | 1,135B | |
| -1.42% | +3.23% | +38.56% | +74.44% | 636B | |
| +0.16% | +0.08% | +25.29% | +95.23% | 505B | |
| -0.31% | +3.09% | +44.14% | +64.80% | 378B | |
| -1.34% | -0.47% | +66.04% | +41.00% | 358B | |
| -0.68% | +2.65% | +22.98% | +50.39% | 295B | |
| -1.20% | +3.04% | +2.33% | +22.86% | 266B | |
| -1.79% | +1.57% | +50.56% | +59.08% | 237B | |
| -0.73% | -0.10% | +29.02% | +99.67% | 193B | |
| Average | -1.93% | +0.94% | +30.85% | +66.98% | 400.44B | |
| Weighted average by Cap. | -1.35% | +2.66% | +41.02% | +79.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | - | -6.9M -7.73M -6.37M -5.78M -10.81M -733M -10.99M -76.71M -30.37M -384M -29M -28.38M -1.21B |
| Net Debt | -62.1M -69.54M -57.37M -51.99M -97.26M -6.6B -98.87M -690M -273M -3.46B -261M -255M -10.9B | -12.9M -14.45M -11.92M -10.8M -20.2M -1.37B -20.54M -143M -56.78M -718M -54.21M -53.06M -2.27B |
Employees
2
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | €6.250 | -9.42% | 1,627 |
| 26-10-22 | €6.900 | -0.72% | 1,064 |
| 26-10-21 | €6.950 | 0.00% | 0 |
| 26-10-20 | €6.950 | 0.00% | 0 |
| 26-10-19 | €6.950 | 0.00% | 0 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6.250EUR
Average target price
15.50EUR
Spread / Average Target
+148.00%
- Stock Market
- Stocks
- MLC Stock
Select your edition
All financial news and data tailored to specific country editions
